By studying biomarkers known to be involved in gastrointestinal cancers, researchers have developed a biomarker algorithm that, when combined with a noninvasive method to collect esophageal cells for study, could give clinicians insight into which patients have esophageal cancer or precancerous conditions such as Barrett’s esophagus (BE) or high-grade dysplasia.
Researchers develop biomarker algorithm for noninvasive detection of Barrett’s esophagus and esophageal cancer
